Department of Medical Biochemistry, Flinders Health and Medical Research Institute, Flinders University, Bedford Park 5042, Australia.
Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Victoria, Australia.
Cells. 2020 Oct 12;9(10):2276. doi: 10.3390/cells9102276.
The insulin-like growth factor (IGF) system regulates metabolic and mitogenic signaling through an intricate network of related receptors and hormones. IGF-II is one of several hormones within this system that primarily regulates mitogenic functions and is especially important during fetal growth and development. IGF-II is also found to be overexpressed in several cancer types, promoting growth and survival. It is also unique in the IGF system as it acts through both IGF-1R and insulin receptor isoform A (IR-A). Despite this, IGF-II is the least investigated ligand of the IGF system. This review will explore recent developments in IGF-II research including a structure of IGF-II bound to IGF-1R determined using cryo-electron microscopy (cryoEM). Comparisons are made with the structures of insulin and IGF-I bound to their cognate receptors. Finally discussed are outstanding questions in the mechanism of action of IGF-II with the goal of developing antagonists of IGF action in cancer.
胰岛素样生长因子 (IGF) 系统通过相关受体和激素的复杂网络调节代谢和有丝分裂信号。IGF-II 是该系统中的几种激素之一,主要调节有丝分裂功能,在胎儿生长和发育过程中尤为重要。IGF-II 也在几种癌症类型中过度表达,促进生长和存活。它在 IGF 系统中也是独特的,因为它通过 IGF-1R 和胰岛素受体同工型 A (IR-A) 发挥作用。尽管如此,IGF-II 是 IGF 系统中研究最少的配体。这篇综述将探讨 IGF-II 研究的最新进展,包括使用冷冻电镜 (cryoEM) 确定 IGF-II 与 IGF-1R 结合的结构。与胰岛素和 IGF-I 与其同源受体结合的结构进行了比较。最后讨论了 IGF-II 作用机制中的悬而未决的问题,以期开发针对癌症中 IGF 作用的拮抗剂。